In person
ZoBio attended the 3rd Biophysics for Drug Discovery Summit 2026 in Boston, a unique, industry-focused forum dedicated exclusively to biophysics. Through case studies, panel discussions, and interactive exchanges, the summit highlights how emerging biophysical technologies are shaping predictive pipelines and accelerating drug discovery.

Marta shared selected case studies demonstrating how biophysical approaches can address diverse discovery challenges – from fragment-based screening for molecular glues, to profiling covalent compounds and antibody – antigen interactions, as well as generating structural models when X-ray crystallography reaches its limits.
Curious to see how these approaches can support complex discovery programs? Download the poster to explore the case studies and insights in more detail.